imatinib has been researched along with Leukemia, Erythroblastic, Acute in 1 studies
Leukemia, Erythroblastic, Acute: A myeloproliferative disorder characterized by neoplastic proliferation of erythroblastic and myeloblastic elements with atypical erythroblasts and myeloblasts in the peripheral blood.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, J | 1 |
| Pan, X | 1 |
| Wang, J | 1 |
| Su, P | 1 |
| Zhang, L | 1 |
| Wei, F | 1 |
| Zhang, J | 1 |
1 other study available for imatinib and Leukemia, Erythroblastic, Acute
| Article | Year |
|---|---|
Synthesis and biological evaluation of novel aromatic-heterocyclic biphenyls as potent anti-leukemia agents.
Topics: Antineoplastic Agents; Biphenyl Compounds; Cell Proliferation; Dose-Response Relationship, Drug; Dru | 2015 |